IBD Pathophysiology and Pharmacology Flashcards
UC/Crohn’s difference in epi
UC has smaller peak in elderly peopulation, but have similar geographic, gender proprtions
To what degree does Crohn’s run in families?
15x increased risk for family members, monozygotic twins = 67% concordance (but 5-15% in US twins)
What is the main gene implicated in IBD?
NOD2
Which GWAS pathways appear involved in both UC and CD?
IL23 and IL12 –> involved in Th17 cells
Will IBD develop in a germ-free environment?
no –> need bacteria
Most common locations of CD
ileum and colon –> lots of bacteria
Th17 cells are activated by….
IL6, 21,23 and TGFbeta
What Ig is secreted in UC?
IgG1 and IgG3
What Ig is secreted in CD?
IgG2
Does smoking increase risk of CD?
yes
Does smoking increase risk of UC?
protective
primary sclerosing cholangitis is more common in UC or CD?
UC –> chronic inflammation of intra/extra hepatic ducts of biliary tree
Risk of PSC
higher risk of colorectal cancer and cholangiocarcinoma
5 classes of pharma agents in IBD
5-ASA, steroids, immunomodulators, anti-TNF, anti-alpha4 inhibitors
Is CD curable?
no
Is UC curable?
yes –> surgery/colectomy
Etiologic factors for more aggressive IBD
tobacco in CD, perianal/penetrating disease, age<40, low albumin/anemia
Tx of mild IBD
short course of steroids, 5 aminosalicylates for UC, budesonide for CD, topical steroid for distal disease
Tx of moderate IBD
immune suppression: thiopurine antimetabolites, methotrexate, anti-tnf, anti-alpha 4 inhibitors
MOA of aminosalicylates
inhibition of T cell proliferation, inhibition of antigen presentation, inhibition of adhesion, decreased TNF production
Indication for aminosalicylates
UC
Adverse events in aminosalicylate use
paradoxical diarrhea, interstitial nephritis
Indication for steroids
induction of remission in moderate/severe UC and CD
Indication for budesonide
induction of remission in CD, standard initial tx for mild CD
Benefit of budesonide
high degree of first pass metabolism reduces side effects
How are immunomodulators Azathioprine and 6MP cleared?
TPMT enzyme –> common mutation can lead to markedly increased active metabolite –> bone marrow suppression
Indication for AZA/6MP
induction and maintenance of remission of CD
How fast do AZA/6MP work?
several months required for full benefit
Adverse effects of AZA/6MP
leukopenia, pancreatitis, hepatitis, infection, malignancy (NHL)
Indication for methotrexate
induction/maintenance of CD remission
Adverse effects of methotrexate
nausea, hepatic fibrosis, teratogenic, ppneumonitis, leukopenia
Indication for cyclosporin A
bridge while waiting for onset of action of AZA/6MP
Adverse effects of cyclosporin A
nephrotoxicity, hypertrichosis, gingival hyperplasia, ht, seizures, liver, etc
3 main anti-TNFs
infliximab, adalimumab, certolizumab pegol
MOA of anti-TNFs
induction of apoptosis of T cells/lymphocytes in lamina propria, cytokine changes/reduction in secretion
Indication for anti-TNFs
induction and maintenance of remission in CD …also, infliximab and adalimumab for UC
Adverse effects of anti-TNFs
transfusion reactions, hypersensitivity, lupus, infection, lymphoma, HSCTL
Are combination anti-TNFs/immunomodulator effective?
yes
MOA natalizumab
block alpha4 integrin –> no binding of leukocytes to wall of blood vessel –> less leukocyte trafficking in gut
Indication for natalizumab
induction/maintenance of CD
Adverse effects for natalizumab
progressive multifocal leukoencephalopathy by reactivation of JC
Are Ab’s useful in CD, UC?
only in CD for complications like fistulae and abscesses
1st line therapy for CD
budesonide
1st line therapy for UC
5asa